---
layout: splash
title: 셀트리온 (068270)
excerpt: 셀트리온의 최근 공시, 수익률, 주요 재무/기술 지표
header:
  overlay_color: "#333"
  show_overlay_excerpt: false
categories:
- KOSPI
- P:의약품
keywords: 셀트리온, 068270
---

| **종가** | **전일대비** | **업종** | **PER** | **PBR** | **DIV** |
| -------: | -----------: | -------: | ------: | ------: | ------: |
| 174,300 | <span style="color: tomato">0.3<small>%</small></span> | P:의약품 | 46.4 | 2.1 | 0.3<small>%</small> |

<!-- more -->


> **기업 개요**<a id="company"></a>

| <span style="white-space:nowrap;">**섹터**</span> | P:의약품 / 기초 의약물질 및 생물학적 제제 제조업 |
| <span style="white-space:nowrap;">**산업**</span> | 램시마, 트룩시마, 허쥬마 |
| <span style="white-space:nowrap;">**상장**</span> | KOSPI / 2018년 2월 9일 상장 / 12월 결산 |
| <span style="white-space:nowrap;">**대표자**</span> | 기우성, 김형기, 서진석 |
| <span style="white-space:nowrap;">**홈페이지**</span> | [http://www.celltrion.com](http://www.celltrion.com){:target="_blank"} |


> **최근 7일 DART 신규 공시**<a id="dart"></a>

| **일자** |      | **보고서명** |
| :------- | :--- | :----------- |
| 06&#x2011;28 | | [임원ㆍ주요주주특정증권등소유상황보고서](https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20240628000955){:target="_blank"} |
|  | | [기타시장안내              (업종변경)](https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20240628800880){:target="_blank"} |
| 06&#x2011;27 | | [주식등의대량보유상황보고서(일반)](https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20240627000653){:target="_blank"} |
| 06&#x2011;24 | | [투자판단관련주요경영사항              (옴리클로CT-P39, 졸레어 바이오시밀러 한국MFDS 품목허가 획득)](https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20240624800462){:target="_blank"} |
| 06&#x2011;21 | | [임원ㆍ주요주주특정증권등소유상황보고서](https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20240621000701){:target="_blank"} |


> **주가 흐름**<a id="price"></a>

![068270](/stock/images/068270.png){: .align-center}


> **주요 가격 변동 지표**<small>[^fn_price_metric]</small>

| **종가** | **전일대비** | **5일** | **20일** | **60일** | **120일** |
| -------: | -----------: | ------: | -------: | -------: | --------: |
| 174,300 | <span style="color: tomato">0.3<small>%</small></span> | <span style="color: cornflowerblue">-1.6<small>%</small></span> | <span style="color: cornflowerblue">-1.7<small>%</small></span> | <span style="color: cornflowerblue">-8.8<small>%</small></span> | <span style="color: cornflowerblue">-24.7<small>%</small></span> |
| **1년** | **편차** | **샤프** | **MDD** | **AvDD** | **MARr** |
| <span style="color: tomato">14.8<small>%</small></span> | 37.7<small>%</small> | 0.39 | -26.1<small>%</small> | -12.6<small>%</small> | -0.6 |


> **주요 재무 지표**<small>[^fn_finance_metric]</small>

| **업종**<small>[^fn_sector_abbr]</small> | **PER** | **PBR** | **DIV** | **평가**<small>[^fn_finance_basic_tags]</small> |
| :--------------------------------------- | ------: | ------: | ------: | ----------------------------------------------: |
| P:의약품 | 46.4 | 2.1 | 0.3<small>%</small> | - |



{% include /commons/ads/adsense.html %}

> **세부 재무/투자 정보 제공 사이트**

| [네이버](https://m.stock.naver.com/domestic/stock/068270/finance/summary){:target="_blank"}<sup><small>모바일</small></sup> | [네이버](https://finance.naver.com/item/coinfo.naver?code=068270){:target="_blank"} | [FnGuide](https://comp.fnguide.com/SVO2/ASP/SVD_Invest.asp?gicode=A068270&MenuYn=Y){:target="_blank"} |
| :---: | :---: | :---: |
| [와이즈리포트](https://comp.wisereport.co.kr/company/c1040001.aspx?cmp_cd=068270){:target="_blank"} | [밸류라인](https://www.valueline.co.kr/finance/summary/068270){:target="_blank"} | [한국경제](https://markets.hankyung.com/stock/068270/financial-summary){:target="_blank"} |


> **주요 기술 지표**<small>[^fn_tech_metric]</small>


![068270](/stock/images/068270_tech.png){: .align-center}

| **기술 지표** | **1년** | **편차** | **샤프** | **MDD** | **AvDD** |
| :------------ | ------: | -----------: | -------: | ------: | -------: |
| 거치식 | 14.8<small>%</small> | 37.7<small>%</small> | 0.39 | -26.1<small>%</small> | -12.6<small>%</small> |
| 적립식[^fn_tech_metric_dca] | 4.4<small>%</small> | 37.3<small>%</small> | 0.12 | -31.0<small>%</small> | -14.1<small>%</small> |
| Sig. M[^fn_tech_metric_sigm] | 57.1<small>%</small> | 29.9<small>%</small> | 1.91 | -10.0<small>%</small> | -3.8<small>%</small> |
| SMA<small><sub>(5)</sub></small>[^fn_tech_metric_sma_i] | 0.3<small>%</small> | 28.5<small>%</small> | 0.01 | -24.7<small>%</small> | -11.5<small>%</small> |
| SMA<small><sub>(20)</sub></small>[^fn_tech_metric_sma_i] | -10.9<small>%</small> | 28.6<small>%</small> | -0.38 | -26.2<small>%</small> | -15.4<small>%</small> |
| SMA<small><sub>(60)</sub></small>[^fn_tech_metric_sma_i] | -9.2<small>%</small> | 28.6<small>%</small> | -0.32 | -41.1<small>%</small> | -15.6<small>%</small> |
| SMA<small><sub>(120)</sub></small>[^fn_tech_metric_sma_i] | 2.8<small>%</small> | 31.0<small>%</small> | 0.09 | -29.9<small>%</small> | -11.4<small>%</small> |
| SMA<small><sub>(240)</sub></small>[^fn_tech_metric_sma_i] | 9.0<small>%</small> | 32.5<small>%</small> | 0.28 | -26.1<small>%</small> | -10.3<small>%</small> |
| MACD[^fn_tech_metric_macd] | -9.6<small>%</small> | 29.0<small>%</small> | -0.33 | -26.5<small>%</small> | -13.7<small>%</small> |


> **주가 흐름 유사 종목**<a id="corr"></a><small>[^fn_corr_long]</small>

![068270](/stock/images/068270_corr.png){: .align-center}

|       | [한진칼](/180640/) | [셀트리온제약](/068760/) | [넷마블](/251270/) |
| :---: | :------------------------------------: | :------------------------------------: | :------------------------------------: |
|       | [코웨이](/021240/) | [에이비엘바이오](/298380/) | [솔브레인](/357780/) |


> **가상 레버리지 상품에 투자했다면**<a id="2x"></a><small>[^fn_lev]</small>

![068270](/stock/images/068270_2x.png){: .align-center}


> **관련 정보**

- [P:의약품 업종 목록](/stats/sector/kospi_업종_의약품_종목/){: .btn .btn--info}

{% include commons/footnotes.md %}